Galleri Multi-Cancer Early Detection Test USD $1,499 A blood test that detects over 70 cancers, many of which are not traditionally screened by standard methods, and is known for helping diagnose tumors years before symptoms present
While BPC-157 excels at localized tissue repair tendons, ligaments, gut lining, and wound sitesTB-500 provides systemic support through complementary mechanisms: Synergistic Benefits When combined as the Wolverine Stack, patients often experience: Faster recovery times local repair accelerated by systemic support Reduced joint stiffness TB-500s effects on tissue elasticity complement BPC-157s local healing Better functional outcomes improved range of motion and load tolerance Enhanced results with other modalities PRP, stem cells, and physical therapy all work more effectively Clinical Protocol for the Wolverine Stack For patients who are candidates for both peptides, a typical protocol includes: BPC-157: 250-500 mcg daily, 5 days/week TB-500: 2.5-5 mg twice weekly Duration: 8-12 weeks for acute conditions, 12-20 weeks for chronic conditions Coordination: Timed with physical therapy, regenerative procedures, and surgical recovery phases Learn More: Wolverine Peptide Stack BPC-157 + TB-500 for Recovery & Repair Read the Blog: The Wolverine Peptide Stack Faster Recovery, Less Pain, Better Healing Safety, Contraindications, and Medical Supervision BPC-157 has an exceptional safety profile in clinical use
Discard it after 28 days regardless of how it looks
In preclinical work, Dihexa promoted dendritic spine formation at concentrations reported to be far more potent than BDNF on a molar basis in specific assays [McCoy et al., 2013]
Injectable administration, specifically subcutaneous (just under the skin), bypasses the digestive system entirely
Novo Nordisk filed for FDA approval on December 18, 2025
